ST LUKE S ROOSEVELT HOSPITAL C has a total of 11 patent applications. Its first patent ever was published in 1994. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are HILDEBRAND WILLIAM H, ATGEN CO LTD and MINOMIC INT LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Analysing materials | |
#4 | Microorganisms | |
#5 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Sordillo Emilia M | 4 |
#2 | Tilson Martin David | 4 |
#3 | Kotler Donald P | 4 |
#4 | Volsky David J | 2 |
#5 | Potash Mary Jane | 2 |
#6 | Smith Roy G | 1 |
#7 | Nakhla Atif M | 1 |
#8 | Rosner William | 1 |
Publication | Filing date | Title |
---|---|---|
US5722396A | Method for estimating creatinine clearance using measurements of body cell mass | |
AU2696395A | A purified 80 kda protein implicated in abdominal aortic aneurysms, antibodies directed thereto, and uses thereof | |
AU7568794A | Hiv (vif)-related compositions, and prophylactic and therapeutic uses thereof |